Biotechnology Value Fund Holds 4‑5% of Xencor Inc. Stock, No Control IntentBiotechnology Value Fund’s passive 4‑5% stake in Xencor Inc. revealed in a 2026 13G filing shows investor interest without control, amid stock volatility.XENCOR INC Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated 18/11/2026, 18:31 2 minutes to read